Brain & Nervous System Migraines Treatment The 6 Types of Migraine Shot By Laura Dorwart Laura Dorwart Laura Dorwart is a health journalist with expertise in disability rights, mental health, and pregnancy-related conditions. She has written for publications like SELF, The New York Times, VICE, and The Guardian. Learn about our editorial process Published on March 13, 2022 Medically reviewed by Diana Apetauerova, MD Medically reviewed by Diana Apetauerova, MD LinkedIn Diana Apetauerova, MD, is board-certified in neurology with a subspecialty in movement disorders. She is an associate clinical professor of neurology at Tufts University. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents CGRP and Migraine Preventative Injections Acute Migraine Injections Other Treatment Frequently Asked Questions There are many treatment options for migraine, including a monthly injectable shot. Migraine is a type of recurring headache. It may cause intense pulsing or throbbing pain, often on one side of the head. A migraine headache may last between four and 72 hours and can involve additional symptoms like nausea, vomiting, vision changes, and sensitivity to light and sound. According to the American Migraine Foundation, around 39 million people in the U.S. experience migraines. Researchers have not yet identified the cause of migraines. Migraine triggers may include stress, anxiety, lack of sleep, certain foods, changes in the weather, loud noises, flashing lights, and more. This article will discuss migraine injections, including types and side effects. Boy_Anupong / Getty Images CGRP and Migraine Calcitonin gene-related peptide (CGRP) is a molecule in the nervous system that may affect migraine severity. Recent studies indicate that CGRP is released during migraines. It promotes vasodilation (widening of the blood vessels), which worsens inflammation and pain. Once it was discovered that CGRP could both trigger migraines and increase their severity, pharmaceutical companies began to develop ways to block CGRP activity in people with chronic migraines. Now, there are several different preventative migraine injections that block either CGRP or CGRP receptors—the molecules to which CGRP proteins bind on cells—using monoclonal antibodies (laboratory-produced immune system proteins that bind to a specific target). What Is CGRP? Calcitonin gene-related peptide, or CGRP, is a neuropeptide (a protein produced by neurons) that plays a role in the nervous system’s ability to regulate pain. What Is Monoclonal Antibody Therapy? Preventative Injections Four injectable prescription medications are available to block CGRP activity: Aimovig, Vypeti, Ajovy, and Emgality. They are all approved by the Food and Drug Administration (FDA) to prevent migraines in adults. Aimovig Aimovig (erenumab) was approved by the FDA in 2018 for the preventative treatment of migraines. In clinical trials, a once-monthly self-injection of Aimovig reduced the number of migraines people experienced each month. Unlike other injectable anti-CGRP medications, Aimovig blocks CGRP receptors rather than binding onto CGRP itself. Ajovy Ajovy (fremanezumab-vfrm), another anti-CGRP migraine injection, is available in both every-month and every-three-month options. In clinical trials, Ajovy reduced the number of headache days each month for people with both chronic and episodic migraines. Vyepti Vyepti (eptinezumab) is a monoclonal antibody that blocks CGRP activity to prevent migraines. Unlike other CGRP antagonists, it’s an intravenous (IV) medication delivered via infusion each month. Trials revealed that Vyepti could reduce the number of headache days in people with chronic migraine by eight days per month. Emgality Emgality (galcanezumab-gnlm) is an anti-CGRP medication, also self-injected monthly, for the prevention of migraines as well as episodic cluster headaches. Episodic cluster headaches are painful, debilitating headaches that usually occur at the same time of day across several weeks or months. In a clinical trial, people who were injected with Emgality experienced 8.7 fewer cluster headaches per week on average. Side Effects Preventative migraine injections have been found to be safe and effective in people between the ages of 18 and 65. Most people who take CGRP monoclonal antibodies don’t experience side effects. Some people reported mild to moderate side effects, such as: Redness, swelling, or pain at the site of injection Constipation Nasal congestion Cramps Muscle spasms Seek Urgent Medical Help In rare cases, anti-CGRP medications could cause an allergic reaction. Seek immediate medical help if you have any of the following symptoms after injection:Swelling in the face, throat, tongue, or extremitiesDifficulty breathingHives (raised welts) or rashFacial flushing Acute Migraine Injections In addition to preventative migraine injections for people with chronic or episodic migraines, two prescribed injectable drugs—sumatriptan and dihydroergotamine (DHE)—have been FDA-approved for the treatment of acute migraines. You can take them at the onset of your migraine to lessen its length and severity. Sumatriptan Sumatriptan is one of the triptans, a class of drugs that treats acute migraine headaches by promoting vasoconstriction (narrowing of the blood vessels). They are also serotonin agonists, which means they bind to serotonin (5-T) receptors in the brain to relieve pain. Sumatriptan is available as a pill, powder, nasal spray, and injection (Imitrex). The injections may be easier to tolerate if you experience vomiting or nausea alongside your other migraine symptoms. Dihydroergotamine Like sumatriptan, the ergot medication dihydroergotamine (DHE) treats acute migraines by promoting vasoconstriction and inhibiting CGRP activity. It’s available in many forms, including via self-injection as DHE 45. It acts quickly to relieve severe migraine headache pain. Side Effects Common side effects of acute migraine injections may include: Hot, cold, or prickly sensations in the extremitiesIrritation, redness, swelling, or pain at the injection site In rare cases, people may experience more severe side effects from an acute migraine injection, such as: Chest pain, pressure, or tightnessPain, pressure, or tightness in the neck, throat, or jawNumbness, dizziness, or weaknessSwellingDifficulty breathing If you experience serious adverse side effects from an acute migraine injection, seek medical help immediately. The Different Types of Migraines Other Treatment In addition to injectable CGRP antagonists, there are several other ways to prevent and treat migraine headaches. These may include: Prescription medications, such as triptans or oral steroids Over-the-counter (OTC) medications, such as non-steroidal anti-inflammatories (NSAIDs) and acetaminophen Hormonal therapy Alternative treatments, such as acupuncture (using thin needles at specific points on the body, which is believed by practitioners to direct energy in the body) Neuromodulation devices, which use electrical currents to affect brain activity Identifying and avoiding migraine triggers, such as certain foods or ingredients Caffeine consumption Applying cold packs Resting in a cool, dark room Getting enough sleep Exercising regularly Stress management Summary Migraine is a common type of chronic headache that causes debilitating, throbbing pain, as well as symptoms like light and sound sensitivity, vision changes, nausea, and vomiting. Calcitonin gene-related peptide (CGRP), a neuropeptide that causes pain and inflammation when released around the brain, can make migraines worse. Several injectable prescription drugs including Aimovig, Ajovy, Vyepti, and Emgality work to prevent migraines by blocking CGRP activity. These medications are delivered monthly via subcutaneous injection or intravenous (IV) infusion. There are also two acute migraine injections—sumatriptan and dihydroergotamine—that can relieve pain during severe migraine attacks. Other possible treatments for migraine may include prescription and over-the-counter (OTC) medications, as well as lifestyle changes like stress management, maintaining a better sleep schedule, and getting regular exercise. A Word From Verywell The pain from migraine headaches can be debilitating and stressful. Talk to your healthcare provider about a referral to a neurologist or another specialist to discuss treatment with migraine injections. Frequently Asked Questions How is migraine diagnosed? To diagnose you with migraine, a healthcare provider will start by asking about your symptoms and medical history. Other possible conditions may be ruled out with imaging and diagnostic tests, such as a computerized tomography (CT) scan or magnetic resonance imaging (MRI).Your provider can make a conclusive diagnosis with a physical and neurological exam. How do you cure a migraine naturally? There are several home remedies and lifestyle changes that can help in preventing and treating migraines. Some examples of home remedies include cold packs, caffeine consumption, and resting in a cool, dark room.Ongoing stress management, hydration, healthy sleep habits, regular exercise, and a nutritious diet can also help. What can cause a migraine? There is no single cause of migraine. Migraine triggers differ from person to person.They may include stress, anxiety, loud noises, bright lights, environmental changes, hormonal changes, certain foods and medications, sleep deprivation, exhaustion from exercise, hunger, tobacco use, and caffeine withdrawal, among others. 15 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. MedlinePlus. Migraine. National Institute of Neurological Disorders and Stroke. Migraine information page. American Migraine Foundation. What is migraine? Mohanty D, Lippmann S. CGRP inhibitors for migraine. Innov Clin Neurosci. 2020;17(4-6):39-40. American Migraine Foundation. What to know about the new anti CGRP migraine treatment options. Food and Drug Administration. FDA approves novel preventive treatment for migraine. Andreou AP, Fuccaro M, Lambru G. The role of erenumab in the treatment of migraine. Ther Adv Neurol Disord. 2020;13:1756286420927119. doi:10.1177/1756286420927119 Food and Drug Administration. Drug trials snapshot: Ajovy. Silberstein S, Diamon M, Hindiyeh NA. Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study. J Headache Pain. 2020 Oct 6;21(1):120. doi:10.1186/s10194-020-01186-3 Food and Drug Administration. FDA approves first treatment for episodic cluster headache that reduces the frequency of attacks. MedlinePlus. Sumatriptan. American Migraine Foundation. Dihydroergotamine (DHE) for migraine treatment. American Academy of Neurology. AAN patient and provider shared decision-making tool | migraine. American Migraine Foundation. Neuromodulation for migraine treatment: An overview. Harvard Health Publishing. If you have migraines, put down your coffee and read this. By Laura Dorwart Laura Dorwart is a health journalist with particular interests in mental health, pregnancy-related conditions, and disability rights. She has published work in VICE, SELF, The New York Times, The Guardian, The Week, HuffPost, BuzzFeed Reader, Catapult, Pacific Standard, Health.com, Insider, Forbes.com, TalkPoverty, and many other outlets. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit